Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 29, 2024 8:45 AM 2 min read

Trump And Biden Supporters Are Worlds Apart On Everything Except For This One Issue

by Maureen Meehan Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

As the United States becomes more and more politically polarized, one issue stands out as a rare point of consensus: cannabis legalization.

In late March 2024, a Pew Research Center survey found that an overwhelming share of U.S. adults (88%) believe marijuana should be legal for medical or recreational use, crossing the vast ideological spectrum for which the U.S. has become known.

Despite this widespread public support, neither of the two main presidential contenders, Joe Biden nor Donald Trump, have fully embraced the issue, say advocates.

But Biden Did This

Biden seems to be having a difficult time moving beyond his stock phrase that "no one should in prison for cannabis." He even said it during his State of the Union address.

And Trump Said That

Fox highlighted the candidates' disconnect from evolving public sentiment around cannabis, saying that despite growing awareness, they've been slow to adapt and therefore risk alienating a significant portion of the electorate, particularly young voters.

"Any candidate that actually wants to get ahead – whether it’s in the presidential election in Congress or state legislatures or local legislators – if they ignore this issue, it’s going to be at their peril," Fox said.

Photo: Created with images from Gage Skidmore on flickr

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisGovernmentNewsPoliticsTop Stories2024 electionDonald TrumpJoe BidenNORMLPew Research CenterStories That Matter
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

At the mid-April National Cannabis Policy Summit in Washington, DC, one of the organizers Caroline Phillips called the candidates’ track records on cannabis inconsistent and incremental, with promises that have yet to materialize in substantial action. "We’ve heard promises from both administrations, neither of which have panned out in full," she told the VOA.

Though Biden took a step toward legalization in August 2022 by directing the Department of Health and Human Services to review marijuana’s classification as a controlled substance, advocates are pushing for full removal from the DEA’s Controlled Substances Act, that is to say, fully de-scheduling marijuana.

Since leaving office, Trump’s remarks have been hazy, reflecting a mixed position that does not clearly align with either side of the legalization debate. Nearly a year ago, he called cannabis "a pretty popular thing" from a voting standpoint. Shortly before that, he said mass shootings were "not a gun problem” but rather blamed them on “genetically engineered” cannabis. Trump has called for the death penalty for drug dealers on various occasions.

Morgan Fox, political director for the National Organization for the Reform of Marijuana Laws (NORML) told the outlet at the DC summit, that Trump has practically avoided the issue of cannabis while on the campaign trail. "We haven’t heard too much from the Republican nominee so far," he said, calling both of the candidates' attitudes out of step with the vast majority of Americans.  

Comments
Loading...